Fibroblast growth factor Thrombin Rac1 RhoA Intracerebral hemorrhage Brain injury Blood-brain barrier Brain edema Behavior Fibroblast growth factors (FGFs) maintain and promote vascular integrity; however whether FGFs protect the blood-brain barrier (BBB) after intracerebral hemorrhage (ICH) remains unexplored. In this present study, we hypothesized that exogenous FGF administration attenuates brain injury after ICH, specifically by preserving endothelial adherens junctions, therefore reducing vasogenic brain edema and attenuating neurofunctional deficits in mice subjected to experimental ICH. Acid fibroblast growth factor (FGF1) or basic fibroblast growth factor (FGF2) was administered intracerebroventricularly (ICV) at 0.5 h after intrastriatal injection of bacterial collagenase (cICH) or autologous whole blood (bICH). Fibroblast growth factor receptor (FGFR) inhibitor PD173074 and phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 were additionally administered with FGF2. The selective Rho-associated coiled-coil forming protein serine/threonine kinase (ROCK) inhibitor Y27632 was independently administered at 0.5 h after cICH. Brain water content and neurofunctional deficits were evaluated at 24 and 72 h after ICH induction. Evans blue extravasation as well as Western blot analysis for the quantification of activated FGFR, Akt, Rasrelated C3 botulinum toxin substrate 1 (Rac1), Ras homolog gene family member A (RhoA) and adherens junction proteins (p120-catenin, β-catenin and VE-cadherin) were conducted at 72 h post-cICH. FGF treatment reduced perihematomal brain edema and improved neurofunctional deficits at 72 h after experimental ICH (pb 0.05, compared to vehicle); however, FGFR and PI3K inhibition reversed these neuroprotective effects. Exogenous FGF2 increased activated FGFR, Akt, and Rac1 but reduced activated RhoA protein expression at 72 h after cICH (pb 0.05, compared to vehicle), which was reversed by FGFR and PI3K inhibition. Y27632 treatment reduced brain injury at 72 h after cICH (pb 0.05, compared to vehicle) and increased the expression of catenins (p120-catenin, β-catenin). In conclusion, our findings suggest that exogenous FGF treatment reduced RhoA activity via FGFR-induced activation of the PI3K-Akt-Rac1 signaling pathway, thus preserving BBB integrity, and therefore attenuating secondary brain injury after experimental ICH in mice.
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Introduction
Intracerebral hemorrhage (ICH) defines a potentially life-threatening neurological emergency, which accounts for 10-15% of all strokerelated hospitalizations (Broderick et al., 1999; Qureshi et al., 2009) . It results in a 30-day mortality rate of approximately 50%, and often causes debilitating neurofunctional deficits in survivors (Aronowski and Hall, 2005) . The development of vasogenic brain edema, as a consequence of increased blood-brain barrier (BBB) permeability, has been identified as an important contributor of secondary brain injury evoked by ICH (Batjer et al., 1990; Elliott and Smith, 2010) . Furthermore, the extent of brain edema highly correlates with the severity of neurofunctional deficits in ICH-patients (Batjer et al., 1990; Elliott and Smith, 2010) .
Thrombin, an essential component in the coagulation cascade, induces the disintegration of endothelial adherens junctions, specifically by stimulation of proteinase-activated receptors (e.g. PAR-1), and subsequent activation of downstream effectors, such as Ras homolog gene family member A (RhoA) and Rho-associated coiledcoil forming protein serine/threonine kinase (ROCK), (Lee et al., 1995; Xi et al., 1998 Xi et al., , 2006 . Activated ROCK directly phosphorylates and therefore disintegrates adherens junction proteins, causing increased BBB permeability and consequent vasogenic edema formation after ICH (van Nieuw Amerongen et al., 2000) .
Fibroblast growth factors (FGFs) are extensively involved in wound healing processes (Ortega et al., 1998) and play an important Neurobiology of Disease 46 (2012) 204-214 
